Company: AVD
Filing Date: 2025-05-29
Form Type: DEF 14A
Source: 0000950170-25-079166
Chunk: 43

Company: AMERICAN VANGUARD CORP
Filing Date: 2025-05-29
Form: DEF 14A
Chunk 43
---
 cash (excluding the nonrecurring

<div align='center'>31</div>

transformation benefit for the CFO, CIO and CHRO), equity and total direct compensation were below the 25thpercentile for the Proxy Peers.

Closing Comments

The Company believes that its executive compensation meets its primary objectives. In the midst of a transformative year, during which net sales were marginally down due to persistently low commodity prices and adjusted EBITDA was within the targeted range, the Company incurred significant nonrecurring charges that generated a net loss. While these necessary measures will lead to an improved balance sheet, the impact on overall financial performance was such that none of the NEOs received an incentive bonus. Consequently, while continuing to receive base wages that are at or above the median of Proxy Peers (on average), the NEOs received total direct compensation that was below the 25thpercentile of its Proxy Peers. In sum, we believe that the Company paid NEOs in a manner consistent with overall company performance.

COMPENSATION COMMITTEE REPORT

The Compensation Committee has reviewed and discussed the Compensation Discussion and Analysis required by Item 402 (b) of Regulation S-K with management and, based on the review and discussions referred to in that Item, the Compensation Committee recommended to the Board that the Compensation Discussion and Analysis be incorporated by reference in the Annual Report on Form 10-K for the year ended December 31, 2024, filed with the SEC.

Marisol Angelini, Chair

Patrick Gottschalk

Steven Macicek

Keith Rosenbloom

<div align='center'>32</div>

EXECUTIVE OFFICERS OF THE COMPANY The following persons are the current executive officers, all of whom are also named executive officers (the “NEOs”) of the Company:

| Name of Director/Officer |     | Age |    |     | Capacity                                                  |
| Douglas A. Kaye III      |     |     | 56 |     | Chief Executive Officer                                   |
| David T. Johnson         |     |     | 68 |     | Vice President, Chief Financial Officer and Treasurer     |
| Timothy J. Donnelly      |     |     | 65 |     | Chief Administrative Officer, General Counsel & Secretary |
| Shirin Khosravi          |     |     | 56 |     | Chief Human Resources Officer                             |
| Peter E. Eilers          |     |     | 61 |     | Managing Director, Amvac Netherlands BV                   |

Douglas A